Halozyme Therapeutics
HALO
#1833
Rank
HK$89.68 B
Marketcap
HK$786.61
Share price
-0.40%
Change (1 day)
43.44%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): HK$27.58

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is HK$27.61. In 2025 the company made an earnings per share (EPS) of HK$20.48 a decrease over its 2024 EPS that were of HK$27.46.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.5834.72%
2025HK$20.48-25.43%
2024HK$27.46
2022HK$11.61-48.07%
2021HK$22.36196.88%
2020HK$7.53-292%
2019-HK$3.92-9.09%
2018-HK$4.31-237.5%
2017HK$3.14-149.38%
2016-HK$6.35211.54%
2015-HK$2.04-52.73%
2014-HK$4.31-24.66%
2013-HK$5.7348.98%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.57-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.34 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.54-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-HK$11.06-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-HK$1.02-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA